SEC Form 4 · accession 0001567619-18-006568
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P Wareham
Director
Period of report
Nov 14, 2018
Accepted (ET)
Nov 16, 2018 · 7:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | holding | — | — | — | 13,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF1 | $101.64 | Nov 14, 2018 | A | 11,442 | A | Nov 11, 2019 | Nov 14, 2025 | ResMed Commmon Stock | 11,442 | 11,442 | D |
Explanation of responses
- F1Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date.